APA (7th ed.) Citation

ACG, v. B., S, M., P, S., T, V., F, H., M, B., . . . JJGHM, B. (2021). Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: A feasibility study. Gastrointestinal endoscopy, 94(1), 111. https://doi.org/10.1016/j.gie.2020.12.021

Chicago Style (17th ed.) Citation

ACG, van Baar, et al. "Duodenal Mucosal Resurfacing Combined with Glucagon-like Peptide-1 Receptor Agonism to Discontinue Insulin in Type 2 Diabetes: A Feasibility Study." Gastrointestinal Endoscopy 94, no. 1 (2021): 111. https://doi.org/10.1016/j.gie.2020.12.021.

MLA (9th ed.) Citation

ACG, van Baar, et al. "Duodenal Mucosal Resurfacing Combined with Glucagon-like Peptide-1 Receptor Agonism to Discontinue Insulin in Type 2 Diabetes: A Feasibility Study." Gastrointestinal Endoscopy, vol. 94, no. 1, 2021, p. 111, https://doi.org/10.1016/j.gie.2020.12.021.